XML 21 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from Operating Activities:    
Net loss $ (6,355,000) $ (4,043,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Bad debt (recovery) expense (18,000) 2,000
Non-cash lease expense from right-of-use assets 0 17,000
Stock-based compensation 169,000 62,000
Non-cash revenue from digital assets (186,000) 0
Non-cash expenses from digital assets 8,000 0
Unrealized loss on digital assets 3,519,000 0
Changes in assets and liabilities:    
Accounts receivable 66,000 236,000
Prepaid expenses and other current assets (140,000) 125,000
Inventory 0 239,000
Other assets 2,000 6,000
Accounts payable 7,000 (107,000)
Accrued expenses and other current liabilities (64,000) 195,000
Deferred revenue (23,000) (121,000)
Lease liabilities 0 (17,000)
Net cash used in operating activities (3,015,000) (3,406,000)
Cash flows from Investing Activities:    
Purchases of digital assets (8,736,000) 0
Net cash used in investing activities (8,736,000) 0
Cash flows from Financing Activities:    
Proceeds from private placement, net of issuance costs 6,888,000 0
Net cash provided by financing activities 9,043,000 2,381,000
Net decrease in cash and cash equivalents (2,708,000) (1,025,000)
Cash and restricted cash at beginning of year 4,965,000 5,990,000
Cash and cash equivalents at end of year 2,257,000 4,965,000
Reconciliation of cash and cash equivalents    
Cash 1,758,000 4,465,000
Current certificates of deposit 500,000 500,000
Total cash and cash equivalents 2,258,000 4,965,000
Non-cash investing and financing activities:    
Common warrant issuance 335,000 0
Series F Preferred Stock conversion 39,000 191,000
Dividends, Preferred Stock 32,000 89,000
Warrants, deemed dividend 0 8,974,000
Common Stock Warrants [Member]    
Cash flows from Financing Activities:    
Proceeds from exercise of common stock warrants, net of costs 1,639,000 903,000
Preferred Warrants [Member]    
Cash flows from Financing Activities:    
Proceeds from exercise of common stock warrants, net of costs $ 516,000 $ 1,478,000